Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.
about
Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision AnalysisAre high drug prices for hematologic malignancies justified? A critical analysis.Costing evidence for health care decision-making in Austria: A systematic review.An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article.Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China.Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation.Trends in annual drug expenditure – a 16 year perspective of a public healthcare maintenance organization.Trends in annual drug expenditure - a 16 year perspective of a public healthcare maintenance organization.How Do We Improve the Impact of Iodine Deficiency Disorders Prevention in Europe and Beyond?
P2860
Q36400944-570F4EF9-5075-4371-8C18-E7A45DFC7283Q38535347-18905BB4-5C51-4113-A80F-F6CBFD597E90Q38642791-549B60CB-12F7-4035-A4AC-84397D949C5AQ38672008-D9C7E446-12E0-4B7A-AD9E-85EE17595B20Q47656490-C58E8BD6-1D47-4843-89BA-7CF145B0F675Q48146023-9DF7521C-AC6F-4943-9C9D-D97FF87B9860Q49329447-E2BA802A-330F-4D97-8227-1ACA6015E398Q51320122-DBE7731F-33CA-4652-BF53-2B4DF48394A3Q57136578-AF69F573-E2DE-450C-AAD9-4A93E2153608
P2860
Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Cost-effectiveness of the sequ ...... t of chronic myeloid leukemia.
@en
Cost-effectiveness of the sequ ...... t of chronic myeloid leukemia.
@nl
type
label
Cost-effectiveness of the sequ ...... t of chronic myeloid leukemia.
@en
Cost-effectiveness of the sequ ...... t of chronic myeloid leukemia.
@nl
prefLabel
Cost-effectiveness of the sequ ...... t of chronic myeloid leukemia.
@en
Cost-effectiveness of the sequ ...... t of chronic myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Cost-effectiveness of the sequ ...... t of chronic myeloid leukemia.
@en
P2093
Annette Conrads-Frank
Beate Jahn
Diana Brixner
Dominik Wolf
Gaby Sroczynski
Günther Gastl
Jerald Radich
Martina Kluibenschaedl
Stefan Schmidt
Ursula Rochau
P2860
P304
P356
10.3109/10428194.2014.982635
P577
2014-11-13T00:00:00Z